Cambridge, MA, United States of America

Arjun Venkat Narayanan

USPTO Granted Patents = 3 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Arjun Venkat Narayanan

Introduction: Arjun Venkat Narayanan is a prominent inventor based in Cambridge, MA, with a remarkable focus on chemical compounds and their applications in medicine. With a total of three patents to his name, Narayanan has significantly contributed to advancements in the treatment of disorders such as sickle cell disease.

Latest Patents: Narayanan's latest inventions specifically revolve around pyrazole derivatives, which are crucial in developing HbS modulators. These modulators hold potential in treating a variety of medical conditions, particularly sickle cell disease (SCD). His patents cover the design and composition of these compounds, along with the processes for their preparation and relevant intermediates.

Career Highlights: Currently, Narayanan is associated with Pfizer Corporation, a leader in the pharmaceutical industry. His work at Pfizer allows him to be at the forefront of research and development in innovative medical treatments. He has achieved impressive recognition for his inventive contributions, making his mark in the field of medicinal chemistry.

Collaborations: Throughout his career, Narayanan has worked alongside talented colleagues such as Ariamala Gopalsamy and Chulho Choi. Their collective expertise has undoubtedly led to meaningful advancements in their research projects and fostered an environment of collaboration and innovation.

Conclusion: Arjun Venkat Narayanan is a noteworthy inventor whose work is paving the way for more effective treatments in the medical field. His patents on pyrazole derivatives illustrate his commitment to innovation and his dedication to improving the lives of those affected by serious health conditions. With a strong foundation at Pfizer Corporation and valuable partnerships in research, Narayanan's future contributions to science and medicine are highly anticipated.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…